EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 62013TA0189

Case T-189/13: Judgment of the General Court of 11 December 2014  — PP Nature-Balance Lizenz v Commission (Medicinal products for human use — Active substance tolperisone — Article 116 of Directive 2001/83/EC — Commission decision ordering the Member States to vary the national marketing authorisations for medicinal products for human use containing the active substance at issue — Burden of proof — Proportionality)

OJ C 34, 2.2.2015, p. 36–36 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

2.2.2015   

EN

Official Journal of the European Union

C 34/36


Judgment of the General Court of 11 December 2014 — PP Nature-Balance Lizenz v Commission

(Case T-189/13) (1)

((Medicinal products for human use - Active substance tolperisone - Article 116 of Directive 2001/83/EC - Commission decision ordering the Member States to vary the national marketing authorisations for medicinal products for human use containing the active substance at issue - Burden of proof - Proportionality))

(2015/C 034/41)

Language of the case: German

Parties

Applicant: PP Nature-Balance Lizenz GmbH (Hamburg, Germany) (represented by: M. Ambrosius, lawyer)

Defendant: European Commission (represented by: initially B. R. Killmann and M. Šimerdová, then B. R. Killmann and A. Sipos, acting as Agents)

Re:

Application for partial annulment of Commission Implementing Decision C(2013) 369 (final) of 21 January 2013 concerning, in the framework of Article 31 of Directive 2001/83/EC of the European Parliament and of the Council, the marketing authorisations for the medicinal products for human use which contain the active substance ‘tolperisone’

Operative part of the judgment

The Court:

1.

Dismisses the action;

2.

Orders PP Nature-Balance Lizenz GmbH to bear its own costs and those incurred by the European Commission.


(1)  OJ C 164, 8.6.2103.


Top